» Articles » PMID: 25850655

Characterization of Host Immunity During Persistent Vaginal Colonization by Group B Streptococcus

Overview
Journal Mucosal Immunol
Publisher Elsevier
Date 2015 Apr 9
PMID 25850655
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Streptococcus agalactiae (Group B Streptococcus, GBS) is a Gram-positive bacterium, which colonizes the vaginal tract in 10-30% of women. Colonization is transient in nature, and little is known about the host and bacterial factors controlling GBS persistence. Gaining insight into these factors is essential for developing therapeutics to limit maternal GBS carriage and prevent transmission to the susceptible newborn. In this work, we have used human cervical and vaginal epithelial cells, and our established mouse model of GBS vaginal colonization, to characterize key host factors that respond during GBS colonization. We identify a GBS strain that persists beyond a month in the murine vagina, whereas other strains are more readily cleared. Correspondingly, we have detected differential cytokine production in human cell lines after challenge with the persistent strain vs. other GBS strains. We also demonstrate that the persistent strain more readily invades cervical cells compared with vaginal cells, suggesting that GBS may potentially use the cervix as a reservoir to establish long-term colonization. Furthermore, we have identified interleukin-17 production in response to long-term colonization, which is associated with eventual clearance of GBS. We conclude that both GBS strain differences and concurrent host immune responses are crucial in modulating vaginal colonization.

Citing Articles

Characterization of the Cellular Immune Response to Group B Streptococcal Vaginal Colonization.

Spencer B, Nguyen D, Marroquin S, Gapin L, OBrien R, Doran K bioRxiv. 2025; .

PMID: 39975125 PMC: 11838357. DOI: 10.1101/2025.01.29.635275.


Mechanisms and Manifestations of Group B Streptococcus Meningitis in Newborns.

Alexander N, Cutts W, Hooven T, Kim B J Pediatric Infect Dis Soc. 2025; 14(2).

PMID: 39927629 PMC: 11808573. DOI: 10.1093/jpids/piae103.


Group B streptococcal infections in pregnancy and early life.

Manuel G, Twentyman J, Noble K, Eastman A, Aronoff D, Seepersaud R Clin Microbiol Rev. 2024; 38(1):e0015422.

PMID: 39584819 PMC: 11905376. DOI: 10.1128/cmr.00154-22.


Transcriptomic analysis reveals activation of oncogenic pathways in cervical adenocarcinoma.

Nguyen H, Le T, Jung D, Jo Y, Choi Y, Lee D Oncol Lett. 2024; 28(6):588.

PMID: 39411203 PMC: 11474141. DOI: 10.3892/ol.2024.14720.


Highly specific vaginal microbiome signature for gynecological cancers.

Han M, Wang N, Han W, Liu X, Sun T, Xu J Open Life Sci. 2024; 19(1):20220850.

PMID: 38633411 PMC: 11022122. DOI: 10.1515/biol-2022-0850.


References
1.
van de Veerdonk F, Gresnigt M, Kullberg B, van der Meer J, Joosten L, Netea M . Th17 responses and host defense against microorganisms: an overview. BMB Rep. 2010; 42(12):776-87. DOI: 10.5483/bmbrep.2009.42.12.776. View

2.
Randis T, Gelber S, Hooven T, Abellar R, Akabas L, Lewis E . Group B Streptococcus β-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo. J Infect Dis. 2014; 210(2):265-73. PMC: 4092248. DOI: 10.1093/infdis/jiu067. View

3.
Kirjavainen P, Pautler S, Baroja M, Anukam K, Crowley K, Carter K . Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections. Clin Vaccine Immunol. 2008; 16(1):29-36. PMC: 2620669. DOI: 10.1128/CVI.00323-08. View

4.
Iwakura Y, Ishigame H . The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006; 116(5):1218-22. PMC: 1451213. DOI: 10.1172/JCI28508. View

5.
Bodaszewska-Lubas M, Brzychczy-Wloch M, Adamski P, Gosiewski T, Strus M, Heczko P . Adherence of group B streptococci to human rectal and vaginal epithelial cell lines in relation to capsular polysaccharides as well as alpha-like protein genes - pilot study. Pol J Microbiol. 2013; 62(1):85-90. View